ArticleEmerging microbes & infections2020
Molecular investigation of infection sources and transmission chains of brucellosis in Zhejiang, China.
Article in Emerging microbes & infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Spatiotemporal dynamics and serosurveillance landscape of brucellosis at the human-animal interface in the Chinese Southwest: A retrospective study.PLoS neglected tropical diseases · 2026Article
- Rapid expansion of human brucellosis in Yunnan, China.BMC infectious diseases · 2026Article
- Integrating epidemiology with genomic tracing to uncover concealed transmission networks in a brucellosis outbreak, Shandong, China.Frontiers in cellular and infection microbiology · 2026Article
- Epidemiological analysis of human brucellosis in North Khorasan province, Iran (2018-2023): a six-year multicenter retrospective study.BMC infectious diseases · 2025Article
- Limited genomic diversity and convergent adaptation ofFrontiers in microbiology · 2025Article
- Retrospective Analysis of the Epidemiological Evolution of Brucellosis in Animals - China, 1951-1989 and 1996-2021.China CDC weekly · 2024Article
- Analysis of the Brucella melitensis epidemic in Xinjiang: genotyping, polymorphism, antibiotic resistance and tracing.Annals of clinical microbiology and antimicrobials · 2024Article
- A scoping review on the epidemiology and public significance ofOne health (Amsterdam, Netherlands) · 2024Article
- Changes in the epidemiological characteristics of human brucellosis in Shaanxi Province from 2008 to 2020.Scientific reports · 2021Article
- Whole-Genome Sequence of a Strain of Brucella melitensis Isolated from a Patient with Swelling of the Right Testicle in Inner Mongolia, China.Microbiology resource announcements · 2021Article
- A Retrospective Survey of the Abortion Outbreak Event Caused by Brucellosis at a Blue Fox Breeding Farm in Heilongjiang Province, China.Frontiers in veterinary science · 2021Article
- Epidemiological, Clinical and Laboratory Characteristics of Patients withInfection and drug resistance · 2021Article
- Article
- Meningoencephalitis, coronary artery and keratitis as an onset of brucellosis: a case report.BMC infectious diseases · 2020Article
- Epidemiologically characteristics of human brucellosis and antimicrobial susceptibility pattern of Brucella melitensis in Hinggan League of the Inner Mongolia Autonomous Region, China.Infectious diseases of poverty · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the present study, a total of 7793 samples from 5 different types of hosts were collected and tested, with a seroprevalence of 2.4% (184/7793). Although the seroprevalence of human and animal brucellosis is relatively low, numbers of human brucellosis cases reported have increased continuously from 2004 to 2018. A total of 118
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.